简介:
Overview
This protocol presents a choroid sprouting assay as an ex vivo model for studying microvascular proliferation, specifically in relation to choroidal angiogenesis and neovascular age-related macular degeneration (AMD). The assay enables the evaluation of pathways involved in choroidal micro vessel proliferation and the assessment of drug treatments using both wild type and genetically modified mouse tissues.
Key Study Components
Research Area
- Choroidal angiogenesis
- Age-related macular degeneration (AMD)
- Microvascular behavior
Background
- Importance of choroidal angiogenesis in eye diseases
- Ex vivo models complementing in vivo studies
- Genetically modified mouse models for enhanced insights
Methods Used
- Choroid sprouting assay
- Use of mouse tissues from wild type and genetically modified strains
- Microscopy for observing choroidal sprouting
Main Results
- The assay allows reproducible measurements of choroidal sprouting across multiple days
- Loss of FFAR4 in knockout mice increased choroidal vascular growth compared to wild type
- Treatment with FFAR4 agonist reduced choroidal sprouting area in knockout mice
Conclusions
- The study demonstrates the assay's efficacy in evaluating anti-angiogenic potential of pharmacological compounds
- It highlights the role of specific signaling pathways in choroidal neovascularization
What is the choroid sprouting assay used for?
It is used to study microvascular proliferation and evaluate potential treatments for neovascular AMD.
How does the assay utilize genetically modified mice?
The assay assesses the effects of specific genetic modifications on choroidal vascular growth.
What are the key findings regarding FFAR4?
FFAR4 knockout mice showed increased choroidal sprouting, while FFAR4 agonist treatment reduced it.
How reproducible is the choroid sprouting assay?
The assay has been shown to produce consistent results for choroidal sprouting over multiple trials.
What roles do choroidal micro vessels play in eye health?
Choroidal micro vessels are crucial for retinal health and their proliferation is linked to eye diseases such as AMD.
What methodologies complement the choroid sprouting assay?
In vivo studies and molecular techniques offer additional insights into microvascular behaviors.
Can this assay assist in drug development?
Yes, it enables screening of compounds that may serve as potential treatments for AMD.